title: Should intravenous N-acetylcysteine be considered standard of care for prevention of radio-contrast-induced nephropathy?
authors.forename: Lindsay
authors.initials: L
authors.lastname: Huxtable
authors.forename: Carrington R K
authors.initials: CR
authors.lastname: Raney
authors.forename: Gordi S
authors.initials: GS
authors.lastname: Khera
mesh_terms: D000111:Acetylcysteine / Q000008:administration & dosage*; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic
chemical_list: D003287:Contrast Media; D000111:Acetylcysteine